Hero Pore Release Blackhead Clearing

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively reduces the number of blackheads and helps maintain clear skin by preventing the formation of new blackheads.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of this product. The affected area should be covered with a thin layer of the product one to three times daily, depending on the patient's needs and the physician's recommendations.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's response, the frequency of application may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the frequency of application to once daily or every other day to alleviate these symptoms.

Contraindications

Use is contraindicated in the following situations:

• Keep out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, seek medical assistance or contact a Poison Control Center immediately.

• Discontinue use and consult a healthcare professional if severe irritation occurs.

• Avoid contact with eyes; in case of contact, flush thoroughly with water.

Warnings and Precautions

For external use only. The application of this product may lead to skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised to use only one topical acne medication at a time.

Care should be taken to avoid contact with the eyes. In the event of contact, it is essential to flush the eyes thoroughly with water. This product must be kept out of reach of children. If ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Users should discontinue use and consult a healthcare professional if severe irritation occurs. Additionally, this product contains an alpha hydroxy acid (AHA), which may heighten the skin's sensitivity to sunlight, increasing the risk of sunburn. Therefore, it is crucial to apply a broad-spectrum sunscreen, wear protective clothing, and limit sun exposure during the use of this product and for at least one week following its discontinuation.

Side Effects

Patients using this product may experience adverse reactions, primarily related to skin irritation and dryness. The likelihood of these reactions increases when another topical acne medication is used concurrently. In such cases, it is advised that patients limit the use to one topical acne medication at a time to minimize the risk of irritation.

Severe irritation is a notable concern; patients should discontinue use and consult a healthcare professional if they experience significant discomfort. Additionally, this product contains an alpha hydroxy acid (AHA), which may heighten the skin's sensitivity to sunlight, increasing the risk of sunburn. To mitigate this risk, patients are advised to apply sunscreen, wear protective clothing, and limit sun exposure during the use of this product and for one week following its discontinuation.

It is important for patients to avoid contact with the eyes. In the event of accidental contact, thorough flushing with water is recommended. This product is intended for external use only.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Hero Pore Release Blackhead Clearing (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

For topical application, it is advised to begin with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily as needed or directed by a healthcare professional. Should patients experience bothersome dryness or peeling, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The product has not been specifically studied in pregnant patients, and therefore, there are no established safety concerns, dosage modifications, or special precautions regarding its use during pregnancy. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. As with any medication, careful consideration and consultation with the patient are recommended to ensure informed decision-making regarding use during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with liver problems.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience severe irritation. When using this product, it is important to note that skin irritation and dryness may be more pronounced if another topical acne medication is used concurrently. Therefore, patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients to avoid contact with the eyes. In the case of accidental contact, patients should flush the eyes thoroughly with water and seek medical advice if necessary.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or as directed by a healthcare professional.

Clinicians should counsel patients to avoid contact with the eyes; in the event of contact, the area should be flushed thoroughly with water. Additionally, the product contains an alpha hydroxy acid (AHA), which may heighten skin sensitivity to sunlight and increase the risk of sunburn. Patients are advised to use sunscreen, wear protective clothing, and limit sun exposure during treatment and for one week following discontinuation.

Drug Information (PDF)

This file contains official product information for Hero Pore Release Blackhead Clearing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)